Sigachi Industries Limited (NSE: SIGACHI, BSE: 543389) is a Hyderabad, Telangana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹1,052 Cr, it ranks #1,570 by market cap among the 6,137 Indian listed companies on FinBizNet, and #48 of 86 in Medicinal Chemicals and Botanical Products. At ₹25.11 (as of 25 Oct 2026), the share price is 38.5% below its 52-week high of ₹40.80 and 50.8% above its 52-week low of ₹16.65. The share price is down 34.4% over one year and down 1.5% over three months.
| Current Price | ₹25.11 |
|---|---|
| Market Cap | ₹1,052 Cr |
| NSE Symbol | SIGACHI |
| BSE Code | 543389 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | -12.4 |
| Return on Equity | -14.50% |
| Return on Assets | 2.69% |
| 52-Week Range | ₹16.65 – ₹40.80 |
| 1-Year Price Change | -34.4% |
| 3-Month Price Change | -1.5% |
| Beta (1Y) | 0.5 |
| Dividend Yield | 0.38% |
| Headquarters | Hyderabad, Telangana |
| Website | sigachi.com |
| Revenue | ₹121 Cr |
|---|---|
| Net Profit | ₹8 Cr |
| Net Margin | 6.7% |
| EPS (Basic) | ₹0.18 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Sigachi Industries Limited manufactures and sells microcrystalline cellulose and cellulose powder in India. The company offers cellulose-based products under the HiCel, AceCel, CoatCel, GloCel, and BARETab names; and various chemicals, including colloidal silicon dioxide, carboxy cellulose sodium and mannitol, etc. to active pharmaceutical ingredients, food and nutrition, cosmetic, and chemical industries. It also provides operations and maintenance services in the fields of speciality chemicals, petrochemicals, water treatment, and pharmaceuticals. In addition, the company exports its products. Sigachi Industries Limited was incorporated in 1989 and is headquartered in Hyderabad, India.
1. Manufacturing & Supply of Microcrystalline Cellulose - Pharmaceutical Excipient-This segment manufactures and sells microcrystalline cellulose powder.
1. Manufacturing and Selling of MCC-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Sigachi Industries Limited | ₹1,052 Cr | -12.4 | -14.50% | ₹121 Cr | -34.4% |
Listed by market capitalisation. Ratios are shown for context only.
Sigachi Industries Limited is trading at ₹25.11, with a market capitalisation of ₹1,052 Cr.
Sigachi Industries Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Sigachi Industries Limited has a P/E of -12.4 and a return on equity of -14.50%.
Sigachi Industries Limited is listed on the NSE under the symbol SIGACHI and on the BSE under the scrip code 543389.
Sigachi Industries Limited's share price is down 34.4% over one year and down 1.5% over three months. Its 52-week range is ₹16.65 to ₹40.80.
In Q1 FY27, Sigachi Industries Limited reported revenue of ₹121 Cr and net profit of ₹8 Cr, with basic EPS of ₹0.18 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.